Impact of enzyme replacement therapy on cardiac morphology and function and late enhancement in Fabry's cardiomyopathy.
Lui
Charles Y
CY
Ju
Hyunsu
H
D009202:Cardiomyopathies / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D000795:Fabry Disease / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D006321:Heart / Q000503:physiopathology; D006352:Heart Ventricles / Q000473:pathology*; D006801:Humans; D006984:Hypertrophy; D011994:Recombinant Proteins / Q000627:therapeutic use; D000519:alpha-Galactosidase / Q000627:therapeutic use
D011994:Recombinant Proteins; D000519:alpha-Galactosidase